Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

N.J. Dermatologist Uses New Treatment for Hair Loss to Regrow and Thicken Follicles Without Surgery
  • USA - English


News provided by

Cosmetic Skin & Surgery Center

Dec 03, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Dermatologist Dr. Jeffrey Rapaport has been successfully using a new, nonsurgical treatment for hair loss in men and women called platelet rich plasma therapy (PRP), which he considers “the best-kept
Dermatologist Dr. Jeffrey Rapaport has been successfully using a new, nonsurgical treatment for hair loss in men and women called platelet rich plasma therapy (PRP), which he considers “the best-kept

Englewood Cliffs, N.J. (PRWEB) December 03, 2014 -- A New Jersey physician has been successfully using a new, nonsurgical treatment for hair loss in men and women that, he insists, could change the entire field of hair restoration.

Dr. Jeffrey A. Rapaport, a dermatologist for 30 years and head of the Cosmetic Skin & Surgery Center, was even featured in a segment on ABC-TV’s “Good Morning, America,” where he called platelet rich plasma therapy (PRP) “the best-kept secret in the world.”

I thought it was too good to be true … so I was very skeptical at the beginning. As time went on, I became more and more of a believer because the results we’re seeing are pretty remarkable in terms of the regrowth in good candidates.

Post this

Up until recently, the only alternatives for treating hair loss were pharmaceuticals – specifically, Minoxidil (such as Rogaine) and DHT blockers (Propecia, for example) – and hair transplantation surgery. PRP is a noninvasive option that targets androgenetic alopecia – the hereditary, profuse thinning of hair that comes with age. Men comprise 70 percent of hair loss sufferers. Although not studied PRP has also been proven effective in some cases of traction alopecia, hair loss found primarily in women due to a pulling force such as that caused by tight ponytails, pigtails or braids.

“I had been researching PRP and read about it – and it sounded so good that I didn’t actually believe it,” he said. “I told myself, ‘This thing cannot work the way they say it works.’ Then I read an article that appeared in Dermatologic Surgery, which is the gold standard for peer-reviewed journals in dermatology. Out of 64 patients in Italy, 62 got successful results. And when they reviewed the improvement, 40 to 60 percent was substantial. So I decided to prescribe it in my own office and and see if I could duplicate the results.”

With PRP, a patient’s blood is drawn and then spun in a centrifuge. The plasma portion is separated from the other portion of the blood by a special gel. The platelets and the growth proteins separate in the tube, and are then collected and injected into the scalp where the hair is thinning.

“I thought it was too good to be true,” Dr. Rapaport said. “I just couldn’t imagine taking someone’s blood, spinning it down, taking the growth factors and being able to get hair growth. So I was very skeptical at the beginning. As time went on, I became more and more of a believer because the results we’re seeing are pretty remarkable in terms of the regrowth in good candidates.”

What makes a good candidate? The best candidate for PRP is someone who has recently started losing hair, Dr. Rapaport said. It won’t work for those who are completely bald, and it won’t regrow all the lost hair. But if there is hair present or hair growing, there’s a chance the technique will work. It is not a replacement for hair transplant surgery.

The treatment is about 40 to 80 percent effective. It doesn’t work on 100 percent of the people and it doesn’t grow 100 percent of the hair back, but there’s a significant amount of improvement with minimal risk and pain.

Dr. Rapaport developed what he calls the “rapid PRP technique,” which is more aggressive because it combines multiple monthly PRP injections with the fairly new technique of microneedling to stimulate hair growth, along with Rogaine.

“Initially I used just the injections, but I found when I used the combination of treatments, we got the best results,” he said. “Our treatments are being done a little more frequently to get the hair to come in a little quicker and more dense before going to the maintenance stage.”

The entire process, including the injection, takes about 60 minutes and costs about $400 or more per session. Dr. Rapaport recommends one treatment per month for the first four months and then two maintenance treatments per year.

“I’ve been administering PRP for six months now, and the results have been quite remarkable,” he said. “It’s not a home run for everybody, but almost everybody saw improvement with the PRP injections. It actually works on most people. I know – because I tried it myself because I had been losing hair on the crown of my head.”

Dr. Rapaport said that throughout his entire career, he has only seen a scant few game-changing significant breakthroughs in the field of dermatology. And he considers using PRP for hair loss to be one of them.

The one thing to note about PRP is that, although the process itself for separating plasma has been approved by the U.S. Food and Drug Administration, injecting into the scalp to treat hair loss has not yet been reviewed. However, Dr. Rapaport noted, PRP has already been used successfully and safely in many other fields of – orthopedics, sports medicine, cosmetic surgery, oral surgery and neurosurgery.

About Jeffrey A. Rapaport, M.D.
Dr. Jeffrey A. Rapaport is Medical Director of Cosmetic Skin & Surgery Center in New Jersey, with offices in Englewood Cliffs and Old Bridge. Certified by the American Board of Dermatology, Dr. Rapaport is a Phi Beta Kappa recipient from Emory University and a graduate of the Emory University School of Medicine in Atlanta, Georgia. After internship at Emory, he completed his advanced training residency at Thomas Jefferson University where he served as chief dermatology resident. He is a clinical instructor at Mount Sinai School of Medicine and Chief of Dermatology at Holy Name Hospital.

Dr. Jeffrey A. Rapaport, Cosmetic Skin & Surgery Center, http://cosmeticskin.com/, (201) 227-1555, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.